2025-12-24

Pharmaceuticals Valuation Drugs, Patents  Trials 

 

Pharmaceuticals Valuation: Drugs, Patents & Trials ??


 Key Drivers
 Pipeline probability of success
 Patent life and exclusivity
 Reimbursement environment

 Approaches
 rNPV (risk-adjusted NPV) for R&D
 Comparable biotech multiples
 Scenario modelling for launch uptake

 Way Forward:
 Diversify portfolio, prepare for generics
 Build strong payer narratives
 

Data Center Valuation: Valuing Digital Infrastructure 
2025-12-31

Data Center Valuation: Valuing Digital Infrastructure 

Read More..
Pharmaceuticals Valuation Drugs, Patents  Trials 
2025-12-24

Pharmaceuticals Valuation Drugs, Patents  Trials 

Read More..
Wearables & Consumer Health Valuation: Data on the Wrist 
2025-12-23

Wearables & Consumer Health Valuation: Data on the Wrist 

Read More..
Energy Storage Valuation: Batteries & Beyond 
2025-12-19

Energy Storage Valuation: Batteries & Beyond 

Read More..
Hospitality & Tourism Valuation: Experience Economics 
2025-12-18

Hospitality & Tourism Valuation: Experience Economics 

Read More..

Frequently Asked Questions

We provide professional valuation services across the following asset classes:
  • Land & Building (Residential, Commercial, Industrial, Agricultural)
  • Plant & Machinery (Manufacturing units, industrial assets)
  • Securities or Financial Assets (Equity shares, debentures, startups, AIFs)
  • Specialized Valuations for M&A, financial reporting, IBC, income tax, and more

Yes, our reports are fully compliant with applicable laws including:
  • Companies Act, 2013
  • SEBI Regulations (SAST, ICDR, AIF)
  • IBC, 2016
  • Income Tax Act, 1961
  • Valuation Standards by ICAI, IBBI, and IVSC

Absolutely. We have IBBI-Registered Valuers under all three categories—Land & Building, Plant & Machinery, and Securities/Financial Assets. Our team also includes experienced chartered accountants and engineers.

We serve a wide range of clients including:
  • Companies & Startups
  • CA & Law Firms
  • Banks & NBFCs
  • Government Departments
  • Individuals & HUFs

Our process is simple and efficient:
  1. Initial consultation to understand the requirement
  2. Document collection and site visit (if needed)
  3. Data analysis and valuation calculation
  4. Final report delivery, certified by a Registered Valuer

Key documents generally include:
  • Ownership/title documents
  • Asset photos or plant list
  • Latest financials
  • Company PAN, GST, or registration
  • Cap tables or investment details (for startups)

Turnaround time:
  • Land/Building or Plant & Machinery: 3–7 working days
  • Financial Assets / Startups: 1–7 working days
  • Fast-track services available on request.

Valuation may be required for:
  • Startup fundraising & ESOPs
  • Business transfers or buyouts
  • Regulatory compliance (SEBI, IBC, Income Tax)
  • Bank loans or mortgages
  • Fair value financial reporting
  • Mergers & Acquisitions

Yes, we specialize in:
  • 409A compliant valuations
  • DCF, NAV, and Berkus method-based startup valuations
  • ESOP pricing & compliance support

Our fees are competitive and project-specific, based on:
  • Nature and size of asset
  • Complexity of engagement
  • Regulatory requirements
  • Contact us for a personalized quote.

Our detailed reports feature:
  • Valuation method and justification
  • Market research & data
  • Key assumptions and disclaimers
  • Final value conclusion
  • Certificate by the Registered Valuer

Yes. We offer remote/desk-based valuation for startups, financial assets, and select use-cases. For physical assets, we usually require on-site verification.

Yes. We offer:
  • Monthly/quarterly retainer packages
  • Bulk valuation pricing for CA firms, legal advisors, banks, and corporates

Yes. Client confidentiality is paramount. All data shared is stored securely and not disclosed to any third party without your consent.

You can get started by:
  • Filling out our Contact Form
  • Calling us directly
  • Scheduling a free consultation